Moving Stocks: Goodrich Petroleum Corp. (NYSE:GDP), Auris Medical Holding AG (NASDAQ:EARS), ONE Gas, Inc. (NYSE:OGS), Anacor Pharmaceuticals (NASDAQ:ANAC), Sypris Solutions (NASDAQ:SYPR)

Goodrich Petroleum Corp. (NYSE:GDP) belongs to Basic Materials sector. Its weekly performance is -4.27%. On last trading day company shares ended up $1.57. Goodrich Petroleum Corp. (NYSE:GDP) distance from 50-day simple moving average (SMA50) is -41.05%. Goodrich Petroleum (NYSE:GDP) had its price objective decreased by SunTrust from $7.00 to $4.00 in a research report released on Thursday morning. SunTrust currently has a buy rating on the stock.

Auris Medical Holding AG (NASDAQ:EARS) shares increased 5.03% in last trading session and ended the day at $5.22. EARS return on assets is -42.50%. Auris Medical Holding AG (NASDAQ:EARS) quarterly performance is -9.38%. On 2 July, Auris Medical Holding AG (NASDAQ:EARS), announced two recent additions to its U.S. intellectual property portfolio. The U.S. Patent and Trademark Office (“USPTO”) has issued an Issue Notification for U.S. Patent Application No. 14/448,999, titled “Methods for the Treatment of Tinnitus Induced by Cochlear Excitotoxicity,” which issued as U.S. Patent No. 9,072,662 on July 7, 2015.

On 10 July, ONE Gas, Inc. Common Stock (NYSE:OGS) shares fell -0.96% and was closed at $43.48. OGS EPS growth in last 5 year was 6.10%. ONE Gas, Inc. Common Stock (NYSE:OGS) year to date (YTD) performance is 7.02%. ONE Gas, Inc. (NYSE:OGS) announced that its Oklahoma Natural Gas division filed a request with the Oklahoma Corporation Commission (OCC) for an increase in base rates, reflecting system investments and operating costs necessary to maintain the safety and reliability of its natural gas distribution system.

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) ended the last trading day at $84.61. Company weekly volatility is calculated as 4.96% and price to cash ratio as 21.16. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) showed a weekly performance of 7.66%. On 29 June, Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced an amendment to its distribution and commercialization agreement with Sandoz Inc., a Novartis company, pursuant to which PharmaDerm, the branded dermatology division of Sandoz, distributes and commercializes KERYDIN® (tavaborole) topical solution, 5%, in the United States. Pursuant to the amendment, Sandoz will increase its commercial investment in KERYDIN in 2015, and Anacor will contribute $20 million to Sandoz, primarily focused on consumer-directed commercialization activities.

Sypris Solutions Inc. (NASDAQ:SYPR) shares increased 5.90% in last trading session and ended the day at $1.47. SYPR Gross Margin is 8.20% and its return on assets is -9.90%. Sypris Solutions Inc. (NASDAQ:SYPR) quarterly performance is 1.52%. Sypris Solutions Inc. (NASDAQ:SYPR) sold the plant’s assets to its largest customer, Meritor. The sale went through late on 9 July, said John McGeeney, general counsel for Sypris.

Leave a Reply

Your email address will not be published. Required fields are marked *